Boutique Diagnostics

Digital Health Market Access Consulting Firm

Digital Health Solutions

EDL

What are the key diagnostics access & policy developments from 2021?

What are the key diagnostics access & policy developments from 2021?

We regularly monitor diagnostics reimbursement and policy developments in various markets. At the end of the year, it is always good to take a pause and look back at the major initiatives. We find the following 7+1 initiatives relevant from 2021 (non-exhaustive list)

,

What’s new in the WHO Essential Diagnostics List 3.0?

,
What’s new in the WHO Essential Diagnostics List 3.0?

The World Health Organisation recently released the third Essential Diagnostics List (EDL), which identifies the most crucial diagnostics low- and middle-income countries (LMICs) should have to fight illnesses ranging from infectious diseases to cancer.

January 2021: What’s new in the world of diagnostics?

January 2021: What’s new in the world of diagnostics?

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

Matching Essential Diagnostics to Treatment for Global Oncology

Matching Essential Diagnostics to Treatment for Global Oncology

The healthcare burden of cancer is growing in low and middle-income countries. How do we ensure that doctors are equipped with the right tools to serve patients from diagnosis to treatment?

September 2020: What’s new in the world of diagnostics?

September 2020: What’s new in the world of diagnostics?

Exciting (NON-Covid19) news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives

What’s hot in (digital) diagnostics? – News in bullets, July -2019

What’s hot in (digital) diagnostics? – News in bullets, July -2019

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

, ,

3+1 Policy Initiatives That Will Influence Diagnostics (IVD) Access

, ,
3+1 Policy Initiatives That Will Influence Diagnostics (IVD) Access

The diagnostics industry is facing increasing policy attention. Policymakers push for broader access, better affordability and safer than ever solutions. Institutions, like the European Union (EU) and World Health Organization (WHO), are involved in introducing new regulations.

Find out what are the latest policy initiatives and how will they impact access for IVD solutions.

,

WHO Essential Diagnostics List (EDL) – 3 likely impacts to the diagnostics industry

,
WHO Essential Diagnostics List (EDL) – 3 likely impacts to the diagnostics industry

WHO Essential Diagnostics List (EDL) – 3 likely impacts to the diagnostics industry

The diagnostics industry is facing increasing policy attention. The In Vitro Diagnostic Device Regulation (IVDR) will newly regulate the European approval system, the new EU Health Technology Assessment (HTA) proposal is already on the table and World Health Organization (WHO) has just released the first Essential Diagnostics List (EDL).

Similar concept, Essential Medicines List (EML) has been around for 40 years. Looking at the history of EML what can the diagnostics industry expect?